Chemo-immunotherapy with dinutuximab beta in patients with relapsed/progressive high risk neuroblastoma: does chemotherapy backbone matter? Status: Published View publication More analysis ongoing Approval date: 05/12/2022
The value of central retrospective reviewing of radiological response within the SACHA-France experience Status: Published View publication Approval date: 26/04/2024
Lorlatinib in patients relapsed/progressive high risk neuroblastoma Status: Published View publication More analysis ongoing Approval date: 02/10/2023
Chemo-Immunotherapy Rescue for High-Risk Neuroblastoma Patients With Progressive Disease Before High-Dose Chemotherapy Status: Published View publication Approval date: 03/10/2025
